企业版公测上线啦!点击立即查看
登录 注册
当前位置: 首页 > 美国USAN数据库 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!

美国在研新药数据库来源于USAN,包括2000年至今的在研新药数据。

通用名 试验代号 CAS号 适应症 研发机构 详情
LOTRAFILCON A 203170-33-3 contact lens material (hydrophilic) Ciba Vision Corporation 查看
NASARUPLASE BETA Abbott-74187; ABT-187 136653-69-5 treatment of acute ischemic stroke Abbott Laboratories 查看
FOSVESET texaphyrin, Gd-Tex, FP-GP1, API-GP3 193901-91-6 ligant excipient Mallinckrodt Inc. 查看
MOTEXAFIN GADOLINIUM PCI-0120; gadolinium texaphyrin, Gd 156436-89-4 antineoplastic Pharmacyclics, Inc. 查看
MOTEXAFIN LUTETIUM PCI-0123; lutetium texaphyrin, Lu texaphyrin, Lu-Tex; FP-LP1 156436-90-7 antineoplastic/antiatherosclerotic Pharmacyclics, Inc. 查看
PEGINTERFERON ALFA-2a Ro 25-8310/000 198153-51-4 treatment of hepatitis C Hoffmann-La Roche, Inc. 查看
RESLIZUMAB SCH 55700 241473-69-8 treatment of bronchial asthma as well as a pharmacological tool to elucidate the role of IL-5 in human eosinophilic diseases Schering-Plough Corporation 查看
TROSPIUM CHLORIDE IP631 treatment of urinary incontinence Maudaus, AG, Germany 查看
ZONIPORIDE MESYLATE CP-597,396-27 249296-45-5 cardioprotective ((Na+-H+ exchanger-1 NHE-1) inhibitor)) Pfizer, Inc. 查看
ROSUVASTATIN CALCIUM ZD4522; S-4522 147098-20-2 antihyperlipidemic (HMGCoA reductase inhibitor) AstraZeneca Pharmaceuticals LP 查看
ENFUVIRTIDE T20; DP178 antiviral (blockade of gp-41 mediated membrane fusion) Trimeris, Inc.; Roche Colorado Corp. 查看
AMOTOSALEN HYDROCHLORIDE S-59 161262-45-9 photochemical treatment (light-activated psoralen derivative intended for use in the inactivation of viruses, bacteria, and leukocytes in platelet concentrates and fresh frozen plasma in blood bank settings) Cerus Corporation 查看
ERTAPENEM SODIUM MK-0826 153832-38-3 antibacterial Merck & Co., Inc. 查看
INGLIFORIB CP-368,296 186392-65-4 treatment of type 2 diabetes mellitus (glycogen phosphorylase inhibitor) Pfizer Inc. 查看
DIBOTERMIN ALFA 246539-15-1 osteoinductive agent for use in orthopaedic surgery, dental/craniofacial surgery, or spine surgery, as an adjunct to standard care or as a replacement for autogenous bone graft Wyeth 查看
PEXELIZUMAB h5G1.1 scFv; h5G1.1 scFv (CDR) complement inhibitor used to reduce the impact of complement-mediated injuries sustained during cardiopulmonary bypass (humanized monoclonal antibody) Alexion Pharmaceuticals, Inc. 查看
ALFUZOSIN HYDROCHLORIDE SL 77 499-10 81403-68-1 treatment of the signs and symptoms of benign prostatic hyperplasia Sanofi-Synthelabo 查看
PRALNACASAN VX-740; HMR3480; HMR3480/VX-740 treatment of rheumatoid arthritis; (interleukin-1βconverting enzyme (also known as caspase-1) inhibitor) Vertex Pharmaceuticals Aventis Pharma AG 查看
SOLIFENACIN SUCCINATE YM905; YM-67905, YM67905 242478-38-2 treatment for relief of symptoms of urinary frequency, urinary urgency, or urge urinary incontinence (UUI) associated with an overactive bladder (muscarinic M3 receptor antagonist) Yamanouchi Pharmaceutical Co, Ltd. 查看
TOFIMILAST CP-325,366 185954-27-2 treatment of asthma and chronic obstructive disease (phosphodiesterase isoenzyme 4)(PDE4 inhibitor) 查看